Results 131 to 140 of about 1,978,039 (213)

Variability in Drug-Drug Interaction Identification Across Commonly Used Drug Information Resources: An Analysis of Real world Tertiary Care Prescriptions (Retrospective Cross sectional Study). [PDF]

J Res Pharm Pract
Verma S, Atal S, Bhavya B, Sadasivam B.
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

A Critical Juncture for Drug Information and Evidence-Based Voices. [PDF]

J Pediatr Pharmacol Ther
Kier K.
europepmc   +1 more source

Explosive drug information in the time of COVID-19. [PDF]

Can Pharm J (Ott), 2021
Schulz M, Schumacher PM, Schneider J, Said A, Laufs U.   +4 more
europepmc   +1 more source

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

Molecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski, Júlia Perera‐Bel, Alejo Rodriguez‐Vida, Nuria Juanpere, Jihyun Lee, Daniel E. Michaud, Jennifer L. Guerriero, Kent W. Mouw, Aristotelis Bamias, Filipe L. F. Carvalho, Joaquim Bellmunt   +10 more
wiley   +1 more source

Sistema Brasileiro de Informação sobre Medicamentos - SISMED

Cadernos de Saúde Pública
Foram descritas as atividades do farmacêutico especialista em informação sobre medicamentos (IM) e caracterizados os Centros de Informação sobre Medicamentos (CIMs), deixando claro o que não são e o que são - mitos e fatos.
Carlos C. F. Vidotti, Rogério Hoefler, Emília Vitória Silva, Gun Bergsten-Mendes   +3 more
doaj  

[Evidence-based drug information for children and adolescents in Germany-Are we moving in the right direction?] [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Möhrle R, Eberl S, Gramlich U, Haering-Zahn J, Ahne G, van der Zanden T, de Wildt S, Rascher W, Neubert A.   +8 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Design and development of a mobile application for drug information and other health data for users and patients of pharmacies and outpatient pharmaceutical services. [PDF]

Explor Res Clin Soc Pharm
Agudelo R, Granados J, Ceballos M, Pereañez JA.   +3 more
europepmc   +1 more source

Usefulness of a Drug Information Resources Website (SAGASU-DI) Created Based on Inquiries to Clinical Pharmacists. [PDF]

Healthcare (Basel), 2022
Murasaka T, Kato H, Sudo H, Iwamoto T.
europepmc   +1 more source